ArticleBone marrow transplantation2026

Long-term survival outcomes of allo-HCT in AML with fludarabine/melphalan conditioning and tacrolimus/sirolimus GVHD prophylaxis.

Amandeep Salhotra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.